Inclusion Criteria:  Male adults Age between 18 and 35 years (limits included); Non-smoking individuals (nor tobacco, nor electronic cigarette nor cannabis, former smokers can be included if they stopped smoking at least 2 years ago); Body Mass Index ≥ 19 and < 30 kg/m2. Considered healthy based on their medical history, clinical examination and biological examination; Subjects capable of and willing to comply with the protocol and to give their written informed consent. Subjects affiliated with a social security scheme.  Non-inclusion Criteria:  Subjects complying with at least one of the following criteria will not be eligible:  Known metabolic abnormality or clinically significant medical condition, such as:  Cardiovascular disease (other than hypertension), Neurological disease, Psychatric disease, Immunological disease, Endocrine disease (including diabetes or thyroid diseases), Chronic kidney disease, Heamatological abnormalities Hypertension (SBP≥160 mm Hg or DBP ≥100 mm Hg). Use of any type of medication or narcotic drug (detected either by the self-declaration of the participant and/ or by the urine TetraHydroCannabinol (THC) test) currently or within the past 2 months before entry into the study; Self-reported alcohol intake of >10 units/ week Weight changes above 10% body weight within the past 6 months before entering the study; Currently under prescribed diet regimen, whatever the reason; Consumption of food supplement(s) currently or within the past 4 weeks before entry into the study, such as but not limited to: botanicals, vitamins, minerals, amino acids; anti-oxydant; Any intolerance or allergy documented or suspected to one of the components of the study products; Subject presenting a psychological or linguistic inability to sign the informed consent; Subject under legal protection (guardianship, wardship) or deprived from his rights following administrative or judicial decision; Subject participating in another biomedical study or participation in another study where a product (ie: dietary supplement) were consumed within the 3 months before entry into this study; Any regulatory reason according to national applicable regulation; Subject having received indemnities for clinical trial reaching at least 4500 Euros considering the last 12 months.  Exclusion criteria :  During the study, in case of emergence of a new health condition or treatment considered as non-inclusion criteria or likely to affect the study parameters according to Investigator's judgment, the participants will be excluded from the study